Simultaneous PET/MRI for the evaluation of hemato-oncological diseases with lower extremity manifestations
A Sauter, M Horger, A Boss, A Kolb, F Mantlik, L Kanz… - 2010 - Soc Nuclear Med
1001 Objectives The study purpose is the evaluation of patients, suffering from hemato-
oncological disease with complications at the lower extremities, using simultaneous …
oncological disease with complications at the lower extremities, using simultaneous …
PET MRI in patients with multiple myeloma
H Zhang, Y Jhanwar, S Dutruel, S Chhabra, JA Kim… - 2018 - Soc Nuclear Med
18 Aim: PET MRI in Multiple Myeloma Patients Objectives: Multiple myeloma (MM) is the
second most common hematological malignancies representing 1% of all malignant …
second most common hematological malignancies representing 1% of all malignant …
PET/MR for evaluation of musculoskeletal malignancies
JS Husseini, R Balza, L Evangelista… - Clinical and …, 2022 - Springer
Purpose To review the existing literature on PET/MR for musculoskeletal malignancies.
Methods PubMed (MEDLINE) was searched through July 2021. The search strategy focused …
Methods PubMed (MEDLINE) was searched through July 2021. The search strategy focused …
PET imaging in hematological malignancies
1008 Objectives: Hematologic cancers are the fifth most commonly occurring cancers and
the second leading cause of cancer death. 18 F-fluorodeoxyglucose positron emission …
the second leading cause of cancer death. 18 F-fluorodeoxyglucose positron emission …
Clinical nononcologic applications of PET/CT and PET/MRI in musculoskeletal, orthopedic, and rheumatologic imaging
A Gholamrezanezhad, K Basques… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. With improvements in PET/CT and PET/MRI over the last decade, as well as
increased understanding of the pathophysiology of musculoskeletal diseases, there is an …
increased understanding of the pathophysiology of musculoskeletal diseases, there is an …
Marrow Replacement Disorders
IR Yoo - Atlas of Nuclear Medicine in Musculoskeletal System, 2022 - Springer
Disorders of the plasma cells and lymphoid progenitor cells will involve the bone marrow as
well as lymphoid tissues. PET/CT utilizing 18F-fluorodeoxyglucose (FDG) is suitable for …
well as lymphoid tissues. PET/CT utilizing 18F-fluorodeoxyglucose (FDG) is suitable for …
Evolving role of PET-computed tomography and PET-MR imaging in assessment of musculoskeletal disorders and its potential revolutionary impact on day-to-day …
applications of PET in primary soft tissue tumors of extremities and also different primary
bone malignancies. The role of PET in the posttherapy setting and evaluation of response to …
bone malignancies. The role of PET in the posttherapy setting and evaluation of response to …
[HTML][HTML] Imaging of plasma cell dyscrasias with FDG-PET/MRI: a single-center experience
Background: By combining the metabolic information of PET with the high soft tissue contrast
of MRI, PET/MRI, most often performed with the glucose analogue [18 F] fluorodeoxyglucose …
of MRI, PET/MRI, most often performed with the glucose analogue [18 F] fluorodeoxyglucose …
Future perspective of the application of positron emission tomography-computed tomography-MR imaging in musculoskeletal disorders
A Angelini, P Castellucci, F Ceci - PET clinics, 2019 - pet.theclinics.com
Computed tomography (CT) and MRI are the preferred anatomically based imaging
modalities in the evaluation of musculoskeletal tumors. In recent years, positron emission …
modalities in the evaluation of musculoskeletal tumors. In recent years, positron emission …
Characterization of multiple myeloma osseous lesions and diffuse infiltration pattern by 18F-FDG-PET/CT, static MRI and diffusion-weighted MR Imaging (DWI-MRI): a …
J Mosebach, C Sachpekidis, N Fard, T Wilhelm… - Cancer Imaging, 2014 - Springer
Aim To compare the detection rates of different imaging modalities for nodular bone marrow
(BM) infiltrates and osteolyses in patients with multiple myeloma (MM). Methods 55 Patients …
(BM) infiltrates and osteolyses in patients with multiple myeloma (MM). Methods 55 Patients …